(Q53229793)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Akiyoshi Takami

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

K Ishiyama

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

T Katagiri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

K Ohata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Y Kondo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

H Yamazaki

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Nakao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

28 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

Transplant Infectious Disease

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

33-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

In search of effective anti-HHV-6 agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00662.X

10.1111/J.1399-3062.2011.00662.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794043%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference